← Open Payments lookup

JENNA CORRAL: Open Payments

NPI 1184236556 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$785 in 38 payments from 10 companies in 2025. Trend: 2023 $19 · 2024 $1,160 · 2025 $785

Food & beverage: $747Education: $39
CompanyPaymentsAmount
ABBVIE INC.13$168
Janssen Pharmaceuticals, Inc4$150
Neurocrine BioSciences, Inc.5$134
Otsuka America Pharmaceutical, Inc.4$88
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$82
Vanda Pharmaceuticals Inc.3$62
E.R. Squibb & Sons, L.L.C.2$42
Takeda Pharmaceuticals U.S.A., Inc.1$21
Supernus Pharmaceuticals, Inc.1$20
Axsome Therapeutics, Inc.1$19

Products named: VRAYLAR, INGREZZA, INVEGA SUSTENNA, CAPLYTA, REXULTI, FANAPT, COBENFY, INVEGA.

Industry payments across TX — which companies pay providers there.